Fully Hydroxyapatite-Coated, Collared, Triple-Taper Stems May Be Safe for all Patients Undergoing Primary Total Hip Arthroplasty: Minimum Two-Year Follow-Up
The Journal of Arthroplasty · 2026-09 · 41 (9) · S246-S251
DOI: 10.1016/j.arth.2026.05.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2026-09. Verfasst von Neeku Salehi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Rothman Orthopaedic Institute, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsyl…. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Hip Prosthesis, Durapatite. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Stryker Corporation.
Abstract (Originalsprache)
INTRODUCTION The triple-tapered, collared, hydroxyapatite-coated stems for cementless total hip arthroplasty (THA) show a low rate of early failure and excellent performance. The purpose of this study was to evaluate the possibility of implanting these stems for any patient undergoing THA, regardless of age and bone quality. METHODS This was a retrospective study at a single institution using a prospectively collected data registry of 265 triple-tapered, collared, fully HA-coated stems implanted for primary cementless THA. We collected data on demographics and clinical outcomes, including the 12-item Short Form/Veterans RAND (SF/VR-12) health survey and Hip Dysfunction and Osteoarthritis Outcomes Score for Joint Replacement (HOOS, JR). Survivorship, revision etiology, and radiographic outcomes were also assessed. The minimum follow-up was two years. The average patient age was 68 years (range, 39 to 89), and their average body mass index was 29.9 (range, 17 to 45). RESULTS The Physical Health SF/VR-12 score increased 0.4 points from a preoperative average of 34.8 (range, 18.4 to 56.6) to a postoperative average of 35.2 (range, 18.1 to 56.6, P = 0.516). The Mental Health SF/VR-12 improvement was 0.7 points from a preoperative average of 50.3 (range, 19.1 to 69.0) to a postoperative average of 51.1 (range, 26.9 to 68.6, P = 0.412). There was a significant improvement of 18.8 points in the HOOS, JR score from a preoperative average of 41.6 (range, 8.1 to 76.8) to a postoperative average of 60.4 (range, 8.1 to 100, P < 0.0001). The two-year survivorship was 98.1%. There were five revisions: two for infection, two for dislocation, and one acetabular periprosthetic fracture (PPFx). Another two patients had a femoral PPFx without requiring femoral component revision. Radiographs demonstrated well-fixed implants in 100%. CONCLUSION Fully HA-coated, triple-tapered cementless component THA offers excellent results at two-year follow-up in an unselected patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Rothman Orthopaedic Institute, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.
- Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
Förderung
- Stryker Corporation
Zitieren
APA
Salehi, N., Stratton Moore, A., Restrepo, C., Smith, E. B., Ong, A. C., & Hozack, W. J. (2026). Fully Hydroxyapatite-Coated, Collared, Triple-Taper Stems May Be Safe for all Patients Undergoing Primary Total Hip Arthroplasty: Minimum Two-Year Follow-Up. The Journal of Arthroplasty, 41(9), S246-S251. https://doi.org/10.1016/j.arth.2026.05.016
Vancouver
Salehi N, Stratton Moore A, Restrepo C, Smith EB, Ong AC, Hozack WJ. Fully Hydroxyapatite-Coated, Collared, Triple-Taper Stems May Be Safe for all Patients Undergoing Primary Total Hip Arthroplasty: Minimum Two-Year Follow-Up. The Journal of Arthroplasty. 2026;41(9):S246-S251. doi:10.1016/j.arth.2026.05.016
BibTeX
@article{Salehi2026,
author = {Salehi, Neeku and Stratton Moore, Alex and Restrepo, Camilo and Smith, Eric B and Ong, Alvin C and Hozack, William J},
title = {Fully Hydroxyapatite-Coated, Collared, Triple-Taper Stems May Be Safe for all Patients Undergoing Primary Total Hip Arthroplasty: Minimum Two-Year Follow-Up},
journal = {The Journal of Arthroplasty},
year = {2026},
volume = {41},
number = {9},
pages = {S246--S251},
doi = {10.1016/j.arth.2026.05.016}
}
EUVIMED